Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease

  • Read more about INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease

Puerto Rico COVID-19 Vaccine Uptake Study

  • Read more about Puerto Rico COVID-19 Vaccine Uptake Study

A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

  • Read more about A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

Rehabilitation for Patients With Persistent Symptoms Post COVID-19

  • Read more about Rehabilitation for Patients With Persistent Symptoms Post COVID-19

Impact of Long COVID-19 on the Health and Quality of Life of Military Personnel (Active or Retired) and Their Families

  • Read more about Impact of Long COVID-19 on the Health and Quality of Life of Military Personnel (Active or Retired) and Their Families

Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

  • Read more about Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants

  • Read more about Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

  • Read more about Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

  • Read more about Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19

  • Read more about Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • Current page 128
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA